Regeneron

News

Regeneron's antibody cocktail active against coronavirus, cu...

Regeneron’s antibody cocktail seems to reduce levels of coronavirus and improve symptoms in patients, according to early test results.

News

Sanofi/Regeneron's Libtayo set for new skin cancer use

Sanofi and Regeneron plan to file their cancer immunotherapy Libtayo (cemiplimab) in a new indication following supportive findings from a phase 2 trial in a hard to treat group of skin can

News

Lilly's antibody therapy cuts hospitalisation rates in COVID...

Eli Lilly has followed up supportive data from its Olumiant in COVID-19 with results of a study showing its antibody treatment could help prevent hospitalisation from the disease.<

News

Regeneron tests COVID-19 antibody therapy in UK's RECOVERY t...

Regeneron’s COVID-19 antibody cocktail has been added to the UK’s RECOVERY trial, one of the largest of its kind in the world that is testing several potential coronavirus therapies at the

News

Sanofi/Regeneron's Kevzara fails again in serious COVID-19 c...

Sanofi has drawn another blank in its attempt to repurpose its IL-6 drug Kevzara to tackle the extreme immune reaction seen in serious cases of COVID-19.

News

Regeneron recruits Roche to make COVID-19 antibody drug REGN...

Roche has agreed to help Regeneron manufacture its COVID-19 antibody cocktail REGN-COV2, which started late-stage clinical testing a few weeks ago, in a deal that could more th

Regeneron's antibody cocktail active against coronavirus, cu...

Sanofi/Regeneron's Libtayo set for new skin cancer use

Lilly's antibody therapy cuts hospitalisation rates in COVID...

Regeneron tests COVID-19 antibody therapy in UK's RECOVERY t...

Sanofi/Regeneron's Kevzara fails again in serious COVID-19 c...

Regeneron recruits Roche to make COVID-19 antibody drug REGN...

CDC panel votes to scrap hepatitis B birth dose advice

How to meet your physicians where they are online

Regeneron

Editor's Picks